Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Growth Potential of the Metabolic Syndrome Market, and How Will It Perform by 2034?

In previous years, the market size of metabolic syndrome has experienced robust growth. It is expected to expand from $84.03 billion in 2024 to $90.60 billion in 2025, showing a compound annual growth rate (CAGR) of 7.8%. The growth seen in the historical phase is due to factors such as the prevalence of sedentary work conditions, the rise in nutraceuticals and functional foods, the growing consumer preference for natural products, an increase in clinical study and trials, as well as healthcare digitalization.

A robust increase is anticipated in the metabolic syndrome market over the forthcoming years, with a predicted market valuation reaching $120.69 billion by 2029, representing a Compound Annual Growth Rate (CAGR) of 7.4%. This predicted growth during the forecast period is linked to escalating stressors in everyday life, increased health consciousness, a surge in the demand for superior diagnostic apparatus, rising instances of diagnostic tests for metabolic disorders, and increased healthcare insurance coverage. Key trends to watch during the forecast period include advancements in medical technology, metabolic health surveillance, the deployment of artificial intelligence, the inclusion of digital health tools, and the advent of smart ingestible pills.

What External and Internal Drivers Are Contributing to the Growth of the Metabolic Syndrome Market’s Growth?

An anticipated surge in the incidence of lifestyle diseases is predicted to propel the metabolic testing market. Lifestyle diseases are primarily health conditions resulting from detrimental habits and unhealthy behaviors rather than genetic or infectious causative agents. Obesity, cancer, type 2 diabetes, osteoporosis, mental health afflictions, and others are typical examples of such conditions. These diseases commonly arise as a result of sedentary living, unhealthy dietary practices, escalating stress, and the widespread consumption of tobacco and alcohol. The metabolic syndrome significantly contributes to the rise of lifestyle diseases by promoting a systemic condition that engenders chronic inflammation, diminished metabolic activities, and elevated cardiovascular risks. For example, the National Health Service England, a governmental department in the UK, reported that the number of cases diagnosed with non-diabetic hyperglycemia, or pre-diabetes, rose by 18% from 3,065,825 cases in 2022 to 3,615,330 cases in 2023. Consequently, the rising prevalence of lifestyle diseases is expected to propel growth in the metabolic testing market.

Explore Comprehensive Insights Into The Global Metabolic Syndrome Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21218&type=smp

Who Are the Major Companies Shaping the Competitive Landscape of the Metabolic Syndrome Market?

Major companies operating in the metabolic syndrome market are Novo Nordisk A/S, Sanofi S.A., Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck KGaA, Amgen Inc., AstraZeneca PLC, Adocia, Biocon Ltd., Bristol-Myers Squibb Company, Cipla Limited, Herbalife International of America Inc., Abbott Laboratories, Shaklee Corporation, Johnson & Johnson Private Limited, Medtronic plc, Apollo, WW International Inc., Jenny Craig, DSM, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Novartis AG, F. Hoffmann-La Roche AG, Merck & Co. Inc.,

What Are the Key Emerging Trends in the Metabolic Syndrome Market for the Next Decade?

In the metabolic syndrome market, leading businesses such as Probi USA are striving to create groundbreaking solutions like clinically supported probiotic solutions to improve the prevention, treatment and management of the condition. These are probiotic offerings validated for its health advantages and security for human use through thorough clinical examinations. For instance, in October 2024, Probi USA, renowned for crafting clinically approved biotics, inaugurated a product known as metabolic health. This product constitutes two probiotic strains – Lactiplantibacillus plantarum 299v (LP299V), and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2). Supported by 230+ publications and eight clinical trials, LP299V enhances cardiovascular wellbeing by bettering cholesterol levels, reducing inflammation, and improving blood vessel function. L. Paracasei 8700:2, documented in 30+ publications, assists with the management of blood pressure, cholesterol, and weight.

Secure Your Global Metabolic Syndrome Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/metabolic-syndrome-global-market-report

What Are the Core Categories and Segments in the Metabolic Syndrome Market Driving Demand and Growth?

The metabolic syndrome market covered in this report is segmented –

1) By Type: Type 1 Metabolic Syndrome, Type 2 Metabolic Syndrome, Type 3 Metabolic Syndrome

2) By Risk Factors: Obesity, Insulin Resistance, High Blood Pressure, High Cholesterol

3) By Treatment: Medication, Lifestyle Changes, Other Treatments

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

5) By End User: Hospitals, Homecare, Specialty Centres, Other End Users

Subsegments:

1) By Type 1 Metabolic Syndrome: Insulin Resistance Syndrome, Abdominal Obesity Syndrome, Hyperglycemia Syndrome

2) By Type 2 Metabolic Syndrome: Elevated Blood Pressure Syndrome, Dyslipidemia Syndrome, Low HDL Cholesterol Syndrome

3) By Type 3 Metabolic Syndrome: Atherosclerotic Cardiovascular Disease Syndrome, Non-Alcoholic Fatty Liver Disease Syndrome, Chronic Inflammation Syndrome

Which Regions Are Making a Mark in the Metabolic Syndrome Market Growth?

North America was the largest region in the metabolic syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolic syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Metabolic Syndrome Market Categorized and Defined in the Industry?

Metabolic syndrome is a group of risk factors that increase a person’s likelihood of developing heart disease, stroke, and type 2 diabetes. It is often linked to poor lifestyle choices, such as unhealthy eating, lack of physical activity, and obesity. Treatment typically focuses on lifestyle changes, such as diet modification, exercise, and medication to manage individual risk factors.

Browse Through More Similar Reports By The Business Research Company:

HyperImmune Globulins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Autoimmune Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Smart Insulin Pens Global Market Report 2025

https://thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: